Opportunity Information: Apply for CDC RFA TP09 902 H1N109
Apply for CDC RFA TP09 902 H1N109
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Public Health Emergency Response (PHER)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.069 Public Health Emergency Preparedness.
- This funding opportunity was created on Jul 9, 2009 and posted on Jul 9, 2009.
- Applicants must submit their applications by Jul 24, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $260,000,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 62 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible Applicants Assistance will be provided only to the health departments of states or their bona fide agents, the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, the Republic of Palau, and the official public health agencies of New York City, New York Los Angeles County, California and Chicago, Illinois. A bona fide agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov. Competition is limited based on Title VIII of the 2009 Supplemental Appropriations Act. CDC will administer 260 million to support domestic disease surveillance, laboratory capacity, laboratory diagnostics, risk communication, rapid response, vaccination planning, and quarantine related to pandemic H1N1 influenza virus preparedness and response.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Public Health Emergency Response (PHER) grant opportunity (Funding Opportunity Number CDC-RFA-TP09-902-H1N109) was a CDC discretionary grant created in response to the 2009 H1N1 influenza pandemic. Its central aim was to bolster and expand the public health infrastructure at the state and local level so jurisdictions could prepare for, respond to, and manage a large-scale infectious disease emergency. The grant was designed to strengthen the core systems that make preparedness possible in practice, including staffing, laboratories, surveillance, and operational readiness for rapid response activities tied to pandemic influenza.
A major focus of PHER was reinforcing the public health workforce and ensuring agencies could sustain or scale staffing to meet surge demands. Alongside workforce support, the program emphasized increasing laboratory capacity and capability, including improving diagnostic readiness and overall lab throughput so jurisdictions could detect and track cases quickly. Strengthening disease surveillance activities was another key objective, with the intent of improving situational awareness, monitoring spread, and supporting decision-making during a fast-moving outbreak. The announcement also highlighted the importance of planning for and potentially implementing mass vaccination activities at scale, recognizing that vaccine operations can require extensive coordination across clinical partners, logistics, storage and distribution systems, and public-facing communication.
The opportunity explicitly supported development of effective public communication and risk communication guidance, reflecting the need for clear, timely messaging during a pandemic. It also supported development of community mitigation guidance, which can include strategies meant to reduce transmission at the community level. In addition, PHER funds could be used for purchasing and procuring pandemic-related supplies such as personal protective equipment (PPE) and antivirals, particularly to protect the public health workforce and support response operations. Training and education of the public health workforce and community and personal preparedness activities were included as allowable and encouraged areas, and the grant aimed broadly at addressing gaps and other preparedness challenges linked to influenza pandemic response.
A practical planning detail embedded in the announcement was that implementation of a vaccination program would be assessed in early September, and applicants were told to build flexibility into planning and mobilization. In other words, jurisdictions were expected to prepare for vaccination at scale but also to structure their plans so they could adapt based on evolving federal guidance, vaccine availability, and the trajectory of the outbreak.
In terms of funding and administrative details, CDC anticipated making 62 awards, with an estimated total funding amount of $260,000,000. The program was tied to CFDA 93.069 (Public Health Emergency Preparedness). There was no cost sharing or matching requirement. The award ceiling and floor were listed as $0 in the announcement data, which typically indicates amounts would be determined by formula, allocation decisions, or other programmatic criteria rather than a fixed per-award cap stated in the synopsis.
Eligibility was limited to governmental public health entities: the health departments of U.S. states (or their bona fide agents), the District of Columbia, Puerto Rico, the U.S. Virgin Islands, the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau, plus the official public health agencies of New York City, Los Angeles County, and Chicago. If an applicant applied as a bona fide agent on behalf of a state or local government, the application required a letter documenting that status, submitted as an attachment through Grants.gov. Competition was limited based on Title VIII of the 2009 Supplemental Appropriations Act, and CDC specified that the $260 million would support domestic disease surveillance, laboratory capacity and diagnostics, risk communication, rapid response, vaccination planning, and quarantine activities related to pandemic H1N1 preparedness and response.
Key timeline information in the listing shows it was posted and created on July 9, 2009, with an original and current closing date of July 24, 2009, and an archive date of August 23, 2009. The administering agency was the Centers for Disease Control and Prevention, and the listed contact for access issues was CDCs Procurement and Grants Office Technical Information Management Section (TIMS) at 770-488-2700.
Frequently Asked Questions (FAQs)
1) What is the name of this grant opportunity?
The opportunity is the Public Health Emergency Response (PHER) grant.
2) What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC-RFA-TP09-902-H1N109.
3) Which agency administered this grant?
The administering agency was the Centers for Disease Control and Prevention (CDC).
4) Why was PHER created?
PHER was a CDC discretionary grant created in response to the 2009 H1N1 influenza pandemic. It was designed to help state and local jurisdictions prepare for, respond to, and manage a large-scale infectious disease emergency.
5) What was the central goal of PHER?
The central aim was to bolster and expand public health infrastructure at the state and local level, strengthening the core systems needed for preparedness and rapid response during pandemic influenza.
6) What types of public health infrastructure did PHER focus on strengthening?
The opportunity emphasized strengthening core preparedness systems, including staffing/workforce, laboratories, disease surveillance, and operational readiness for rapid response activities tied to pandemic influenza.
7) Was supporting the public health workforce an allowable use of PHER funds?
Yes. A major focus of PHER was reinforcing the public health workforce and enabling agencies to sustain or scale staffing to meet surge demands during a pandemic response.
8) Did PHER support laboratory capacity and diagnostics?
Yes. The program emphasized increasing laboratory capacity and capability, including improving diagnostic readiness and overall lab throughput so jurisdictions could detect and track cases quickly.
9) Did PHER support disease surveillance activities?
Yes. Strengthening disease surveillance was a key objective, intended to improve situational awareness, monitor spread, and support decision-making during a fast-moving outbreak.
10) Did the grant cover planning for mass vaccination?
Yes. PHER highlighted planning for and potentially implementing mass vaccination activities at scale, recognizing the operational complexity of vaccine coordination, logistics, storage and distribution, and public-facing communication.
11) Was implementation of a vaccination program guaranteed under PHER?
No. The announcement noted that implementation of a vaccination program would be assessed in early September, and applicants were instructed to build flexibility into planning and mobilization based on evolving guidance, vaccine availability, and outbreak trajectory.
12) Did PHER support public communication and risk communication?
Yes. The opportunity explicitly supported development of effective public communication and risk communication guidance to enable clear, timely messaging during a pandemic.
13) Did PHER support community mitigation guidance?
Yes. The grant supported development of community mitigation guidance, including strategies intended to reduce transmission at the community level.
14) Could PHER funds be used to purchase response supplies?
Yes. PHER funds could be used for purchasing and procuring pandemic-related supplies such as personal protective equipment (PPE) and antivirals, particularly to protect the public health workforce and support response operations.
15) Were training and education activities included?
Yes. Training and education of the public health workforce were included as allowable and encouraged areas, along with community and personal preparedness activities.
16) What broader gaps was PHER intended to address?
The grant aimed broadly at addressing gaps and other preparedness challenges linked to influenza pandemic response, across workforce, laboratory, surveillance, communications, and operational readiness.
17) How many awards did CDC anticipate making?
CDC anticipated making 62 awards.
18) What was the estimated total funding amount?
The estimated total funding amount was $260,000,000.
19) What CFDA number was associated with this opportunity?
The opportunity was tied to CFDA 93.069 (Public Health Emergency Preparedness).
20) Was there a cost sharing or matching requirement?
No. The opportunity stated there was no cost sharing or matching requirement.
21) What were the award ceiling and award floor?
The award ceiling and floor were listed as $0 in the announcement data, which typically indicates the per-award amounts were not stated as fixed caps in the synopsis and would be determined by formula, allocation decisions, or other programmatic criteria.
22) Who was eligible to apply?
Eligibility was limited to governmental public health entities, including health departments of U.S. states (or their bona fide agents), the District of Columbia, Puerto Rico, the U.S. Virgin Islands, the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau, plus the official public health agencies of New York City, Los Angeles County, and Chicago.
23) Could an organization apply as a bona fide agent on behalf of a state or local government?
Yes. If an applicant applied as a bona fide agent, the application required a letter documenting that status, submitted as an attachment through Grants.gov.
24) Was the competition limited?
Yes. Competition was limited based on Title VIII of the 2009 Supplemental Appropriations Act.
25) What response areas did CDC specify the $260 million would support?
CDC specified the funding would support domestic disease surveillance, laboratory capacity and diagnostics, risk communication, rapid response, vaccination planning, and quarantine activities related to pandemic H1N1 preparedness and response.
26) When was the opportunity posted?
The listing shows the opportunity was posted and created on July 9, 2009.
27) What was the closing date?
The original and current closing date shown in the listing was July 24, 2009.
28) When was the opportunity archived?
The archive date listed was August 23, 2009.
29) Who should applicants contact for access issues?
The listed contact for access issues was CDC's Procurement and Grants Office Technical Information Management Section (TIMS) at 770-488-2700.
30) Was this opportunity specifically tied to pandemic H1N1?
Yes. The opportunity was created in response to the 2009 H1N1 influenza pandemic and focused on preparedness and response activities related to pandemic influenza, including H1N1.
Browse more opportunities from the same category: Health
Next opportunity: Valuing Ecosystem Goods and Services Provided by Nati
Previous opportunity: RECOVERY Trail Maintenance / Repair
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA TP09 902 H1N109
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA TP09 902 H1N109) also looked into and applied for these:
| Funding Opportunity |
|---|
| Support for Implementation and Expansion of HIV Prevention, Care and Treatment Services at National Teaching and Referral Hospitals (NT RHs) As Centers of Excellence in the Republic of Kenya Under The President s Emergency Fund for AIDS Relief (PEPF Apply for CDC RFA PS10 1004 Funding Number: CDC RFA PS10 1004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Strengthening Health Outcomes through the Private Sector (SHOPS) Apply for M OAA GH POP 09 0709 Funding Number: M OAA GH POP 09 0709 Agency: Agency for International Development Category: Health Funding Amount: $200,000,000 |
| Grants to States for Loan Repayment Apply for HRSA 09 228 Funding Number: HRSA 09 228 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NHLBI Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral MD/PhD Fellows (F30) Apply for PA 09 232 Funding Number: PA 09 232 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Partnerships with Product Development Public Private Partnerships (R01) Apply for RFA AI 09 034 Funding Number: RFA AI 09 034 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of New Technologies Needed for Studying the Human Microbiome (R01) Apply for RFA RM 09 008 Funding Number: RFA RM 09 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of New Technologies Needed for Studying the Human Microbiome (R21) Apply for RFA RM 09 009 Funding Number: RFA RM 09 009 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Epidemiological MCH/SPH Institute Apply for HRSA 09 265 Funding Number: HRSA 09 265 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Short Term Research Education Program to Increase Diversity in Health Related Research (R25) Apply for RFA HL 10 013 Funding Number: RFA HL 10 013 Agency: National Institutes of Health Category: Health Funding Amount: $106,250 |
| Revolutionary Genome Sequencing Technologies The 1000 Genome (R01) Apply for RFA HG 09 011 Funding Number: RFA HG 09 011 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Revolutionary Genome Sequencing Technologies The 1000 Genome (R21) Apply for RFA HG 09 012 Funding Number: RFA HG 09 012 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Revolutionary Genome Sequencing Technologies The 1000 Genome (SBIR R43/R44) Apply for RFA HG 09 013 Funding Number: RFA HG 09 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Awards to Support Research on the Biology of Aging in Invertebrates (R01) Apply for RFA AG 10 004 Funding Number: RFA AG 10 004 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| AHRQ Grants for Health Services Research Dissertation Program (R36) Apply for PAR 09 212 Funding Number: PAR 09 212 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $40,000 |
| Increasing Immunization Rates through Healthcare Provider Partnerships Apply for CDC RFA IP09 903 Funding Number: CDC RFA IP09 903 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Childhood Immunization Support Project Apply for CDC RFA IP09 904 Funding Number: CDC RFA IP09 904 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Rural Health Network Development Planning Grant Program Apply for HRSA 10 020 Funding Number: HRSA 10 020 Agency: Health Resources and Services Administration Category: Health Funding Amount: $85,000 |
| Coordination of Activities between the CDC, NCIRD, and State and Local Immunization Programs Apply for CDC RFA IP09 905 Funding Number: CDC RFA IP09 905 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $278,000 |
| Best Practices in Child Welfare Project Apply for USAID RUSSIA OH 09 0002 RFA Funding Number: USAID RUSSIA OH 09 0002 RFA Agency: Russia USAID Moscow Category: Health Funding Amount: $8,500,000 |
| Supplement for Implementing Training of the Sexually Transmitted Disease (STD) Program Management Course Apply for CDC RFA PS06 60601SUPP09 Funding Number: CDC RFA PS06 60601SUPP09 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA TP09 902 H1N109", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.